BTSG · BrightSpring Health Services, Inc. · Documents

$71.21 -0.24 (-0.34%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 400 member Russell 2000 member Rebalance outlook locked

Market Cap

$14.17B

198.98M

Volume · Nov 13 1.35M Avg daily vol (3M) 2.42M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025

Mar 6

Earnings call

Q4 2024 earnings call

Mar 6

Current report 8-K

Financial results

Mar 6

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $11.27B ▲ 27.6% Net loss $18.06M Diluted EPS -$0.09

Mar 5

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Jan 21

Current report 8-K Events of Jan 17

Entered into a material agreement, Regulation FD disclosure

2024

Dec 11

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure

Nov 15

Current report 8-K Events of Nov 12

Director or officer change, or executive pay

Nov 1

Earnings call

Q3 2024 earnings call

Nov 1

Current report 8-K

Financial results

Nov 1

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $2.91B ▲ 28.8% Net loss $8.23M Diluted EPS -$0.04

Oct 11

Current report 8-K

Director or officer change, or executive pay

Sep 30

Current report 8-K Events of Sep 27

Director or officer change, or executive pay, Regulation FD disclosure

Aug 2

Earnings call

Q2 2024 earnings call

Aug 2

Current report 8-K

Financial results

Aug 2

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $2.73B ▲ 26.0% Net income $19.92M ▲ 399.5% Diluted EPS $0.10 ▲ 233.3%

Jun 24

Current report 8-K Events of Jun 17

Unregistered sale of equity

May 31

Current report 8-K

Director or officer change, or executive pay

May 2

Earnings call

Q1 2024 earnings call

May 2

Current report 8-K

Financial results

May 2

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $2.58B ▲ 27.0% Net loss $45.75M Diluted EPS -$0.26

Apr 26

Current report 8-K

Director or officer change, or executive pay

Mar 6

Annual report 10-K Ended Dec 31

Annual report for the period ended Dec 31, 2023

Feb 29

Earnings call

Q4 2023 earnings call

Feb 29

Current report 8-K

Financial results

Feb 23

Current report 8-K Events of Feb 21

Entered into a material agreement, New debt or off-balance-sheet obligation

Jan 30

Current report 8-K Events of Jan 25

Entered into a material agreement, Ended a material agreement, Change to shareholders' rights, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events

Jan 25

Registration statement S-1/A

Registration statement

Jan 17

Registration statement S-1/A

Registration statement

Jan 10

Registration statement S-1/A

Registration statement

Jan 2

Registration statement S-1

Registration statement

2022

Jan 14

Registration statement S-1/A

Registration statement

Jan 4

Registration statement S-1/A

Registration statement

2021

Nov 2

Registration statement S-1/A

Registration statement

Oct 18

Registration statement S-1

Registration statement

Showing 51–84 of 84 documents

Key facts CIK 1865782 CUSIP 10950A106 13F (30d) 345 filings 331 filers Visit website Investor relations